Results

Total Results: 1,253 records

Showing results for "developed".

561. Archived: Preeclampsia: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/preeclampsia-screening-1996
     January 01, 1996 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Recommendation Statement Preeclampsia: Screening January 01, 1996 Recommendations made by the USPSTF are independent of the U.S. government. They should …

562. Archived: Evidence Summary (Pregnant and Postpartum Women): Screening for Depression in Adults | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-primary-care-screening-for-and-treatment-of/depression-in-adults-screening
     January 26, 2016 - and older and pregnant or postpartum (within 1 year of birth at enrollment) and living in "very high-developed … meet criteria for fair or good quality (ie, it was poor quality) using study design–specific criteria developed … a Quality assessed using criteria developed by the US Preventive Services Task Force. 16 b Group … a Quality assessed using criteria developed by the US Preventive Services TaskForce. 16 b Group assignment … a Quality assessed using criteria developed by the US Preventive Services Task Force 16 for randomized

563. Archived: Evidence Summary: Breast Cancer: Medications for Risk Reduction | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary27/breast-cancer-medications-for-risk-reduction-2013
     April 15, 2013 - Key questions were developed through the Effective Health Care Program and modified for the USPSTF. … Study Selection We developed selection criteria for studies based on the patient populations, interventions … As a group, investigators used methods developed by the USPSTF to assess the overall quality of the body … From these data, the model was developed to allow the prediction of individualized absolute risk (probability … & Developed using secondary data sources with inadequate description of the population and duration

564. Archived: Visual Impairment: Screening, 1996 | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/visual-impairment-screening-1996
     January 01, 1996 - for vision screening in children, outlining which tests to use and criteria for referral, have been developed

565. First Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/tfannrpt2011.pdf
     January 01, 2012 - The University of Washington Medical School has developed a similar program for medical students enrolled … To encourage research that closes critical evidence gaps identified by the USPSTF, the Task Force developed … Recently developed technologies hold promise for extending the reach of colorectal cancer screening … the 10 leading preventable risk factors for years of healthy life lost to death and disability in developed

566. Archived: Final Research Plan: Syphilis Infection in Pregnant Women: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/syphilis-infection-in-pregnancy-screening-september-2018
     August 31, 2017 - Share to Facebook Share to X Share to WhatsApp Share to Email Print archived Final Research Plan Syphilis Infection in Pregnant Women: Screening August 31, 2017 Recommendations made by the USPSTF are independent of the U.S. government. The…

567. Screening and Treatment for Major Depressive Disorder in Children and Adolescents: Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/MZB7xxWHfLHtcdT9uUHsrp
     April 01, 2009 - Screening Tests Instruments developed for primary care (Patient Health Questionnaire for Adolescents

568. Procedure Manual Appendix X. Factors to Consider When Recommending Screening Intervals | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-x-factors-consider-when-recommending-screening-intervals
     July 01, 2017 - Procedure Manual Appendix X. Factors to Consider When Recommending Screening Intervals Share to Facebook Share to X Share to WhatsApp Share to Email Print Evidence regarding the following factors should be considered when recommending a scree…

569. Screening for Asymptomatic Bacteriuria in Adults: Evidence for the U.S. Preventive Services Task Force Reaffirmation Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/RoC9VuSorM_LR7sTvLeFF2
     July 01, 2008 - Patients in either group who developed symptomatic urinary infections were also treated with the study

570. Archived: Diabetes Mellitus (Type 2) in Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/recommendation/diabetes-mellitus-type-2-in-adults-screening-2008
     June 15, 2008 - Definitions of diabetes were originally developed by using results of 2-hour postload plasma glucose … The criterion for an abnormal fasting plasma glucose level was developed on the basis of 2-hour postload

571. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(6).pdf
     November 01, 2014 - High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress HIGH-PRIORITY EVIDENCE GAPS FOR CLINICAL PREVENTIVE SERVICES Fourth Annual REPORT TO CONGRESS November 2014 SUBMITTED BY: Dr. Michael LeFevre, Chair Dr. Kirsten Bibbins-Domingo, Vice Chair Dr. Albert Siu, Vice Chair ON …

572. High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annlrpt2014%20(9).pdf
     November 01, 2014 - High-Priority Evidence Gaps for Clinical Preventive Services Fourth Annual Report to Congress HIGH-PRIORITY EVIDENCE GAPS FOR CLINICAL PREVENTIVE SERVICES Fourth Annual REPORT TO CONGRESS November 2014 SUBMITTED BY: Dr. Michael LeFevre, Chair Dr. Kirsten Bibbins-Domingo, Vice Chair Dr. Albert Siu, Vice Chair ON …

573. High-Priority Evidence Gaps For Clinical Preventive Services: 7th Annual Report to Congress (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/annual-report-to-congress-2017%20(2).pdf
     January 01, 2017 - These organizations and agencies provide input on the recommendations as they are being developed and

574. Archived: Final Evidence Summary: Low-Dose Aspirin Use for the Prevention of Morbidity and Mortality From Preeclampsia: Preventive Medication | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary51/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication-september-2014
     April 08, 2014 - based MFMU (Maternal-Fetal Medicine Units) trial instructed women to stop treatment if preeclampsia developed … Preterm birth is the cause of 70% of neonatal mortality and 75% of neonatal morbidity in developed countries

575. Final Research Plan: Cognitive Impairment in Older Adults: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/cognitive-impairment-in-older-adults-screening
     October 19, 2017 - Share to Facebook Share to X Share to WhatsApp Share to Email Print Final Research Plan Cognitive Impairment in Older Adults: Screening October 19, 2017 Recommendations made by the USPSTF are independent of the U.S. government. They should no…

576. Archived: Evidence Summary: Chronic Obstructive Pulmonary Disease: Screening | United States Preventive Services Taskforce
     www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/chronic-obstructive-pulmonary-disease-screening-2016
     April 05, 2016 - Scope of the Review To conduct this review, an analytic framework was developed … Although the LFQ was specifically developed in the National Health and Nutrition Examination Survey population

577. Screening for Chronic Obstructive Pulmonary Disease: USPSTF Recommendation Statement (pdf file)
     www.uspreventiveservicestaskforce.org/home/getfilebytoken/_ZPNC3vqdS3R-ggXro6UAM
     April 05, 2016 - Screening for Chronic Obstructive Pulmonary Disease: USPSTF Recommendation Statement Copyright 2016 American Medical Association. All rights reserved. Screening for Chronic Obstructive Pulmonary Disease US Preventive Services Task Force Recommendation Statement US Preventive Services Task Force (USPSTF) T he US Pre…

578. Eighth Annual Report to Congress on High-Priority Evidence Gaps for Clinical Preventive Services (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/usptf-annual-report-congress-2018%20(1).pdf
     January 01, 2018 - These organizations and agencies provide input on the recommendations as they are being developed and

579. Task Forces Issues Draft Recommendation Statement on Folic Acid Supplementation to Prevent Neural Tube Defects (pdf file)
     www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/file/supporting_documents/folic-acid-suppl-draft-rec-bulletin.pdf
     March 20, 2023 - Task Forces Issues Draft Recommendation Statement on Folic Acid Supplementation to Prevent Neural Tube Defects www.uspreventiveservicestaskforce.org 1 Task Force Issues Draft Recommendation Statement on Folic Acid Supplementation to Prevent Neural Tube Defects Taking folic acid before and during early…

580. Screening for Syphilis: A Brief Update (pdf file)
     www.uspreventiveservicestaskforce.org/USPSTF_Admin/Home/GetFile/1/996/syphilup/pdf
     July 01, 2004 - with a group given a single benzathine penicillin G injection.31 None of the patients in either group developed … New tests are being developed, particularly those related to on-site testing or improved testing in newborns